BRIEF-Vifor Pharma Enters Into Commercial Collaboration In US With Janssen

1 Min Read

Nov 4 (Reuters) - VIFOR PHARMA AG:

* ENTERS INTO COMMERCIAL COLLABORATION IN US WITH JANSSEN

* AGREEMENT TO JOINTLY COMMERCIALISE NEW DIABETIC KIDNEY DISEASE (DKD) INDICATION FOR INVOKANA(®) (CANAGLIFLOZIN) IN US Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below